TY - JOUR
T1 - Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor
AU - Barettino, Domingo
AU - Ruiz, María D.M.Vivanco
AU - Stunnenberg, Hendrik G.
PY - 1994
Y1 - 1994
N2 - Transcriptional activation by nuclear receptors is achieved through autonomous activation functions (AFs), a constitutive N-terminal AF-1 and a C-terminal, ligand-dependent AF-2 that comprises a motif conserved between nuclear receptors. We have performed an extensive mutational analysis of the putative AF-2 domain of chicken thyroid hormone receptor alpha (cT3Rα). We show that the AF-2 region mediates transactivation as well as transcriptional interference (squelching), not only between the thyroid hormone and vitamin (type II) receptors, but also between type II and steroid hormone (type I) receptors. Transcriptional activation and interference require equivalent doses of the cognate ligand, and mutations in the conserved motif that reduce ligand-induced transactivation also impair transcriptional interference. When fused to the Ga14 DNA binding domain, a 35 amino acid long fragment containing the conserved motif is able to transactivate and squelch, albeit in a ligand-independent manner. Our results define the AF-2 of cT3Rα as an autonomous transactivation domain that, in its natural context, is governed by ligand. We propose that AF-2 is probably part of a surface for interaction with either a general transcription factor or a putative bridging factor, that might be utilized by type I and II receptors.
AB - Transcriptional activation by nuclear receptors is achieved through autonomous activation functions (AFs), a constitutive N-terminal AF-1 and a C-terminal, ligand-dependent AF-2 that comprises a motif conserved between nuclear receptors. We have performed an extensive mutational analysis of the putative AF-2 domain of chicken thyroid hormone receptor alpha (cT3Rα). We show that the AF-2 region mediates transactivation as well as transcriptional interference (squelching), not only between the thyroid hormone and vitamin (type II) receptors, but also between type II and steroid hormone (type I) receptors. Transcriptional activation and interference require equivalent doses of the cognate ligand, and mutations in the conserved motif that reduce ligand-induced transactivation also impair transcriptional interference. When fused to the Ga14 DNA binding domain, a 35 amino acid long fragment containing the conserved motif is able to transactivate and squelch, albeit in a ligand-independent manner. Our results define the AF-2 of cT3Rα as an autonomous transactivation domain that, in its natural context, is governed by ligand. We propose that AF-2 is probably part of a surface for interaction with either a general transcription factor or a putative bridging factor, that might be utilized by type I and II receptors.
KW - Nuclear receptors
KW - Thyroid hormone receptor
KW - Transactivation domain
KW - Transcriptional interference
UR - http://www.scopus.com/inward/record.url?scp=0028233763&partnerID=8YFLogxK
U2 - 10.1002/j.1460-2075.1994.tb06603.x
DO - 10.1002/j.1460-2075.1994.tb06603.x
M3 - Article
C2 - 8039499
AN - SCOPUS:0028233763
SN - 0261-4189
VL - 13
SP - 3039
EP - 3049
JO - EMBO Journal
JF - EMBO Journal
IS - 13
ER -